riferminogene pecaplasmide
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Sanofi-aventis is developing riferminogene pecaplasmide, a fibroblast growth factor 1 (FGF-1; NV1FGF) gene therapy for the…
(-)-Epigallocatechin gallate, Abafungin, ACE-031, Adapalene/benzoyl peroxide, AE-37, Aflibercept, AGS-003, Albiglutide…